U.S, January 19, 2020 (OPENACCESSNEWS) Michael Jacobs, marketing and creative content specialist at GotVape.com offers his insight into how medical marijuana has the potential to help people lose weight.
Using marijuana and losing weight might seem like a contradiction. One of its most well-known effects...
UNITED KINGDOM, October 9, 2019, (HEALTH EUROPA) - Zelda Therapeutics Limited has announced a proposed merger of equals with Ilera Therapeutics LLC (Ilera Therapeutics).
Ilera Therapeutics is a privately held medical cannabis and cannabinoid science company based in the United States and, subject to approval from Zelda shareholders and all conditions of sale being met,...
The potential of therapeutic cannabis is real. Since 1995, there have been over 25,000 peer-reviewed articles in various medical journals in the U.S. and around the world about the plant’s medicinal characteristics and potential for therapeutic use. Also during that time, over 30 states have approved medical cannabis programs...
AUSTRALIA, Ocotber 8, 2019, (CANNABISNOW) In the decades since the medical marijuana movement began in earnest in the 1970s, cannabis has been anecdotally touted as an effective treatment for a variety of illnesses, including those impacting brain function, such as seizures, anxiety and depression. However, peer-reviewed research into the...
U.S, November 29, 2019 (CANNABISNOW) Fear-driven misinformation is permeating the national conversation about the vaping-related deaths. Here’s what you need to know.
A wave of vaping-related pulmonary illness is shaking up America. The first reported illnesses first broke out over the summer and have now killed dozens and sickened thousands...
U.S., September 30, 2019 (MERRY JANE)- A compound found in cannabis, cannabidivarin or CBDV, could vastly augment our medical marijuana treatment arsenal.
When Dr. Sanjay Gupta and CNN premiered the medical cannabis documentary Weed six years ago, they introduced the world to CBD. After convincing the public that cannabis could treat otherwise...





